Characterisation of gene expression profiles of yeast cells expressing BRCA1 missense variants

European Journal of Cancer

Volumn 45, Issue 12, 2009, Pages 2187-2196

  Di Cecco, Leontina ^a   Melissari, Erika ^a   Mariotti, Veronica ^a   Iofrida, Caterina ^a   Galli, Alvaro ^b   Guidugli, Lucia ^a   Lombardi, Grazia ^a   Caligo, Maria Adelaide ^a   Iacopetti, Paola ^a   Pellegrini, Silvia ^a  

^a UNIVERSITY OF PISA   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

BRCA1 gene; Cell proliferation; DNA repair; Gene expression; Genome stability; Microarray analysis; Missense mutations; Saccharomyces cerevisiae

Indexed keywords

ARTICLE; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC RECOMBINATION; MICROARRAY ANALYSIS; MISSENSE MUTATION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; YEAST CELL;

BLOTTING, WESTERN; BRCA1 PROTEIN; CELL PROLIFERATION; FEMALE; GERM-LINE MUTATION; HUMANS; MUTATION, MISSENSE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SACCHAROMYCES CEREVISIAE;

EID: 67650941241     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.04.025     Document Type: Article

References (94)

1. Fackenthal J.D., and Olopade O.I. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7 12 (2007) 937-948
2. Zhang J., and Powell S.N. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res 3 10 (2005) 531-539
3. Deng C.X., and Brodie S.G. Roles of BRCA1 and its interacting proteins. Bioessays 22 8 (2000) 728-737
4. Bhattacharyya A., Ear U.S., Koller B.H., Weichselbaum R.R., and Bishop D.K. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem 275 31 (2000) 23899-23903
5. Xu X., Aprelikova O., Moens P., Deng C.X., and Furth P.A. Impaired meiotic DNA-damage repair and lack of crossing-over during spermatogenesis in BRCA1 full-length isoform deficient mice. Development 130 9 (2003) 2001-2012
6. Zhong Q., Boyer T.G., Chen P.L., and Lee W.H. Deficient nonhomologous end-joining activity in cell-free extracts from BRCA1-null fibroblasts. Cancer Res 62 14 (2002) 3966-3970
7. Deng C.X. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res 34 5 (2006) 1416-1426
8. Deming P.B., Cistulli C.A., Zhao H., et al. The human decatenation checkpoint. Proc Natl Acad Sci USA 98 21 (2001) 12044-12049
9. Aprelikova O.N., Fang B.S., Meissner E.G., et al. BRCA1-associated growth arrest is RB-dependent. Proc Natl Acad Sci USA 96 21 (1999) 11866-11871
10. Mullan P.B., Quinn J.E., and Harkin D.P. The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene 25 43 (2006) 5854-5863
11. Humphrey J.S., Salim A., Erdos M.R., Collins F.S., Brody L.C., and Klausner R.D. Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing. Proc Natl Acad Sci USA 94 11 (1997) 5820-5825
12. Skibbens R.V., Ringhoff D.N., Marzillier J., Cassimeris L., and Eastman L. Positional analyses of BRCA1-dependent expression in Saccharomyces cerevisiae. Cell Cycle 7 24 (2008) 3928-3934
13. Caligo M.A., Bonatti F., Guidugli L., Aretini P., and Galli A. A yeast recombination assay to characterize human BRCA1 missense variants of unknown pathological significance. Hum Mutat 30 1 (2009) 123-133
14. Monteiro A.N., August A., and Hanafusa H. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc Natl Acad Sci USA 93 24 (1996) 13595-13599
15. Tischkowitz M., Hamel N., Carvalho M.A., et al. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach. Eur J Hum Genet 16 7 (2008) 820-832
16. Carvalho M.A., Marsillac S.M., Karchin R., et al. Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. Cancer Res 67 4 (2007) 1494-1501
17. Judkins T., Hendrickson B.C., Deffenbaugh A.M., et al. Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations. Cancer Res 65 21 (2005) 10096-10103
18. Tavtigian S.V., Deffenbaugh A.M., Yin L., et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 43 4 (2006) 295-305
19. Smyth G. Limma: linear models for microarray data. In: Gentleman R., Carey V., Dudoit S., Irizarry R., and Huber W. (Eds). Bioinformatics and computational biology solutions using R and bioconductor (2005), Springer, New York 397-420
20. Lonnstedt I., and Speed T. Replicated microarray data. Stat Sinica 12 (2002) 31-46
21. Benjamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Meth) 57 1 (1995) 289-300
22. Vandesompele J., De Preter K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3 7 (2002) 78 RESEARCH0034
23. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29 9 (2001) e45
24. Prado F., and Aguilera A. Partial depletion of histone H4 increases homologous recombination-mediated genetic instability. Mol Cell Biol 25 4 (2005) 1526-1536
25. Celeste A., Petersen S., Romanienko P.J., et al. Genomic instability in mice lacking histone H2AX. Science 296 5569 (2002) 922-927
26. Kelly T.J., Qin S., Gottschling D.E., and Parthun M.R. Type B histone acetyltransferase Hat1p participates in telomeric silencing. Mol Cell Biol 20 19 (2000) 7051-7058
27. Yuen K.W., Warren C.D., Chen O., Kwok T., Hieter P., and Spencer F.A. Systematic genome instability screens in yeast and their potential relevance to cancer. Proc Natl Acad Sci USA 104 10 (2007) 3925-3930
28. Nagy M., Le Gouar M., Potier S., Souciet J.L., and Herve G. The primary structure of the aspartate transcarbamylase region of the URA2 gene product in Saccharomyces cerevisiae. Features involved in activity and nuclear localization. J Biol Chem 264 14 (1989) 8366-8374
29. McIntosh E.M., and Haynes R.H. Sequence and expression of the dCMP deaminase gene (DCD1) of Saccharomyces cerevisiae. Mol Cell Biol 6 5 (1986) 1711-1721
30. Hernando Y., Carter A.T., Parr A., Hove-Jensen B., and Schweizer M. Genetic analysis and enzyme activity suggest the existence of more than one minimal functional unit capable of synthesizing phosphoribosyl pyrophosphate in Saccharomyces cerevisiae. J Biol Chem 274 18 (1999) 12480-12487
31. Guillet M., Van Der Kemp P.A., and Boiteux S. DUTPase activity is critical to maintain genetic stability in Saccharomyces cerevisiae. Nucleic Acids Res 34 7 (2006) 2056-2066
32. Aguilera A. The connection between transcription and genomic instability. Embo J 21 3 (2002) 195-201
33. Fan H.Y., Merker R.J., and Klein H.L. High-copy-number expression of Sub2p, a member of the RNA helicase superfamily, suppresses hpr1-mediated genomic instability. Mol Cell Biol 21 16 (2001) 5459-5470
34. Kang X., Hu Y., Li Y., et al. Structural, biochemical, and dynamic characterizations of the hRPB8 subunit of human RNA polymerases. J Biol Chem 281 26 (2006) 18216-18226
35. Krapp S., Kelly G., Reischl J., Weinzierl R.O., and Matthews S. Eukaryotic RNA polymerase subunit RPB8 is a new relative of the OB family. Nat Struct Biol 5 2 (1998) 110-114
36. Wu W., Nishikawa H., Hayami R., et al. BRCA1 ubiquitinates RPB8 in response to DNA damage. Cancer Res 67 3 (2007) 951-958
37. Paunesku T., Mittal S., Protic M., et al. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol 77 10 (2001) 1007-1021
38. Moldovan G.L., Pfander B., and Jentsch S. PCNA controls establishment of sister chromatid cohesion during S phase. Mol Cell 23 5 (2006) 723-732
39. Watts F.Z. Sumoylation of PCNA: wrestling with recombination at stalled replication forks. DNA Repair (Amst) 5 3 (2006) 399-403
40. MacLachlan T.K., Somasundaram K., Sgagias M., et al. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J Biol Chem 275 4 (2000) 2777-2785
41. Yao N., Coryell L., Zhang D., et al. Replication factor C clamp loader subunit arrangement within the circular pentamer and its attachment points to proliferating cell nuclear antigen. J Biol Chem 278 50 (2003) 50744-50753
42. Refsland E.W., and Livingston D.M. Interactions among DNA ligase I, the flap endonuclease and proliferating cell nuclear antigen in the expansion and contraction of CAG repeat tracts in yeast. Genetics 171 3 (2005) 923-934
43. Johansson E., Garg P., and Burgers P.M. The Pol32 subunit of DNA polymerase delta contains separable domains for processive replication and proliferating cell nuclear antigen (PCNA) binding. J Biol Chem 279 3 (2004) 1907-1915
44. Qiu J., Qian Y., Frank P., Wintersberger U., and Shen B. Saccharomyces cerevisiae RNase H(35) functions in RNA primer removal during lagging-strand DNA synthesis, most efficiently in cooperation with Rad27 nuclease. Mol Cell Biol 19 12 (1999) 8361-8371
45. Gerik K.J., Li X., Pautz A., and Burgers P.M. Characterization of the two small subunits of Saccharomyces cerevisiae DNA polymerase delta. J Biol Chem 273 31 (1998) 19747-19755
46. Linder T., and Gustafsson C.M. The Soh1/MED31 protein is an ancient component of Schizosaccharomyces pombe and Saccharomyces cerevisiae mediator. J Biol Chem 279 47 (2004) 49455-49459
47. Giavara S., Kosmidou E., Hande M.P., et al. Yeast Nhp6A/B and mammalian Hmgb1 facilitate the maintenance of genome stability. Curr Biol 15 1 (2005) 68-72
48. Krogan N.J., Lam M.H., Fillingham J., et al. Proteasome involvement in the repair of DNA double-strand breaks. Mol Cell 16 6 (2004) 1027-1034
49. Marston N.J., Richards W.J., Hughes D., Bertwistle D., Marshall C.J., and Ashworth A. Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals. Mol Cell Biol 19 7 (1999) 4633-4642
50. Zhang J., and Powell S.N. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Mol Cancer Res 3 10 (2005) 531-539
51. Piatti S., Lengauer C., and Nasmyth K. Cdc6 is an unstable protein whose de novo synthesis in G1 is important for the onset of S phase and for preventing a 'reductional' anaphase in the budding yeast Saccharomyces cerevisiae. Embo J 14 15 (1995) 3788-3799
52. Schwob E., and Nasmyth K. CLB5 and CLB6, a new pair of B cyclins involved in DNA replication in Saccharomyces cerevisiae. Gene Dev 7 7A (1993) 1160-1175
53. Dirick L., Bohm T., and Nasmyth K. Roles and regulation of Cln-Cdc28 kinases at the start of the cell cycle of Saccharomyces cerevisiae. Embo J 14 19 (1995) 4803-4813
54. Biggins S., and Murray A.W. The budding yeast protein kinase Ipl1/Aurora allows the absence of tension to activate the spindle checkpoint. Gene Dev 15 23 (2001) 3118-3129
55. Longhese M.P., Paciotti V., Fraschini R., Zaccarini R., Plevani P., and Lucchini G. The novel DNA damage checkpoint protein ddc1p is phosphorylated periodically during the cell cycle and in response to DNA damage in budding yeast. Embo J 16 17 (1997) 5216-5226
56. Sugimoto K., Shimomura T., Hashimoto K., Araki H., Sugino A., and Matsumoto K. Rfc5, a small subunit of replication factor C complex, couples DNA replication and mitosis in budding yeast. Proc Natl Acad Sci USA 93 14 (1996) 7048-7052
57. Wang H., and Elledge S.J. DRC1, DNA replication and checkpoint protein 1, functions with DPB11 to control DNA replication and the S-phase checkpoint in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 96 7 (1999) 3824-3829
58. Tyers M., Tokiwa G., and Futcher B. Comparison of the Saccharomyces cerevisiae G1 cyclins: Cln3 may be an upstream activator of Cln1, Cln2 and other cyclins. Embo J 12 5 (1993) 1955-1968
59. Nasmyth K., and Dirick L. The role of SWI4 and SWI6 in the activity of G1 cyclins in yeast. Cell 66 5 (1991) 995-1013
60. Hateboer G., Wobst A., Petersen B.O., et al. Cell cycle-regulated expression of mammalian CDC6 is dependent on E2F. Mol Cell Biol 18 11 (1998) 6679-6697
61. Abid M.R., Li Y., Anthony C., and De Benedetti A. Translational regulation of ribonucleotide reductase by eukaryotic initiation factor 4E links protein synthesis to the control of DNA replication. J Biol Chem 274 50 (1999) 35991-35998
62. Jensen R.A., Page D.L., and Holt J.T. Identification of genes expressed in premalignant breast disease by microscopy-directed cloning. Proc Natl Acad Sci USA 91 20 (1994) 9257-9261
63. Fan H., Villegas C., and Wright J.A. Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential. Proc Natl Acad Sci USA 93 24 (1996) 14036-14040
64. Nordlund P., and Reichard P. Ribonucleotide reductases. Annu Rev Biochem 75 (2006) 681-706
65. Fan H., Huang A., Villegas C., and Wright J.A. The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments. Proc Natl Acad Sci USA 94 24 (1997) 13181-13186
66. Lambrechts M.G., Bauer F.F., Marmur J., and Pretorius I.S. Muc1, a mucin-like protein that is regulated by Mss10, is critical for pseudohyphal differentiation in yeast. Proc Natl Acad Sci USA 93 16 (1996) 8419-8424
67. Lorenz M.C., and Heitman J. The MEP2 ammonium permease regulates pseudohyphal differentiation in Saccharomyces cerevisiae. Embo J 17 5 (1998) 1236-1247
68. Kubler E., Mosch H.U., Rupp S., and Lisanti M.P. Gpa2p, a G-protein alpha-subunit, regulates growth and pseudohyphal development in Saccharomyces cerevisiae via a cAMP-dependent mechanism. J Biol Chem 272 33 (1997) 20321-20323
69. Chandarlapaty S., and Errede B. Ash1, a daughter cell-specific protein, is required for pseudohyphal growth of Saccharomyces cerevisiae. Mol Cell Biol 18 5 (1998) 2884-2891
70. Bardwell L., Cook J.G., Zhu-Shimoni J.X., Voora D., and Thorner J. Differential regulation of transcription: repression by unactivated mitogen-activated protein kinase Kss1 requires the Dig1 and Dig2 proteins. Proc Natl Acad Sci USA 95 26 (1998) 15400-15405
71. Tedford K., Kim S., Sa D., Stevens K., and Tyers M. Regulation of the mating pheromone and invasive growth responses in yeast by two MAP kinase substrates. Curr Biol 7 4 (1997) 228-238
72. Martin H., Mendoza A., Rodriguez-Pachon J.M., Molina M., and Nombela C. Characterization of SKM1, a Saccharomyces cerevisiae gene encoding a novel Ste20/PAK-like protein kinase. Mol Microbiol 23 3 (1997) 431-444
73. Palecek S.P., Parikh A.S., and Kron S.J. Sensing, signalling and integrating physical processes during Saccharomyces cerevisiae invasive and filamentous growth. Microbiology 148 Part 4 (2002) 893-907
74. Vega F.M., and Ridley A.J. Rho GTPases in cancer cell biology. FEBS Lett 582 14 (2008) 2093-2101
75. Rakha E.A., Boyce R.W., Abd El-Rehim D., et al. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Modern Pathol 18 10 (2005) 1295-1304
76. Carraway III K.L., Funes M., Workman H.C., and Sweeney C. Contribution of membrane mucins to tumor progression through modulation of cellular growth signaling pathways. Curr Top Dev Biol 78 (2007) 1-22
77. Hofmann C., Shepelev M., and Chernoff J. The genetics of PAK. J Cell Sci 117 Part 19 (2004) 4343-4354
78. Baugher P.J., Krishnamoorthy L., Price J.E., and Dharmawardhane S.F. Rac1 and Rac3 isoform activation is involved in the invasive and metastatic phenotype of human breast cancer cells. Breast Cancer Res 7 6 (2005) R965-R974
79. Li F., Adam L., Vadlamudi R.K., et al. P21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells. EMBO Rep 3 8 (2002) 767-773
80. Vadlamudi R.K., Adam L., Wang R.A., et al. Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells. J Biol Chem 275 46 (2000) 36238-36244
81. Cao Y., Cairns B.R., Kornberg R.D., and Laurent B.C. Sfh1p, a component of a novel chromatin-remodeling complex, is required for cell cycle progression. Mol Cell Biol 17 6 (1997) 3323-3334
82. Cairns B.R., Erdjument-Bromage H., Tempst P., Winston F., and Kornberg R.D. Two actin-related proteins are shared functional components of the chromatin-remodeling complexes RSC and SWI/SNF. Mol Cell 2 5 (1998) 639-651
83. Carey M., Li B., and Workman J.L. RSC exploits histone acetylation to abrogate the nucleosomal block to RNA polymerase II elongation. Mol Cell 24 3 (2006) 481-487
84. Osley M.A., and Shen X. Altering nucleosomes during DNA double-strand break repair in yeast. Trends Genet 22 12 (2006) 671-677
85. Neely K.E., and Workman J.L. The complexity of chromatin remodeling and its links to cancer. Biochim Biophys Acta 1603 1 (2002) 19-29
86. Bochar D.A., Wang L., Beniya H., et al. BRCA1 is associated with a human SWI/SNF-related complex: linking chromatin remodeling to breast cancer. Cell 102 2 (2000) 257-265
87. Versteege I., Sevenet N., Lange J., et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394 6689 (1998) 203-206
88. Christman M.F., Dietrich F.S., and Fink G.R. Mitotic recombination in the rDNA of S. cerevisiae is suppressed by the combined action of DNA topoisomerases I and II. Cell 55 3 (1988) 413-425
89. Holm C., Stearns T., and Botstein D. DNA topoisomerase II must act at mitosis to prevent nondisjunction and chromosome breakage. Mol Cell Biol 9 1 (1989) 159-168
90. Andrews C.A., Vas A.C., Meier B., et al. A mitotic topoisomerase II checkpoint in budding yeast is required for genome stability but acts independently of Pds1/securin. Gene Dev 20 9 (2006) 1162-1174
91. Wang J.Y., and Edelmann W. Mismatch repair proteins as sensors of alkylation DNA damage. Cancer Cell 9 6 (2006) 417-418
92. Wang Y., Cortez D., Yazdi P., Neff N., Elledge S.J., and Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Gene Dev 14 (2000) 927-939
93. Yamane K., Schupp J.E., and Kinsella T.J. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage. Cancer Res 67 13 (2007) 6286-6292
94. Kinzler K.W., and Vogelstein B. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386 6627 (1997) 761-763